BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 114238
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114238
Figure 1
Figure 1 Kaplan-Meier analysis of progression-free survival by risk stratification and immunological status. A: Estimates of progression-free survival according to risk group; B: Progression-free survival stratified by tumor stage and CD16+CD56+ natural killer cell percentage. PFS: Progression-free survival; NK: Natural killer.


Write to the Help Desk